Four TP53 mutations (E343*, R248Q, H179R and H193R) are commonly shared by ESCC cell lines and patient tissues (Fig. 3D), which may make them feasible candidates for in vivo and in vitro precision research. The gene discussed is TP53; the disease is esophageal squamous cell carcinoma.